| Leveraging heterogeneity in systemic lupus erythematosus for new therapies ME Allen, V Rus, GL Szeto Trends in molecular medicine 27 (2), 152-171, 2021 | 65 | 2021 |
| Targeted delivery of chloroquine to antigen-presenting cells enhances inhibition of the type I interferon response ME Allen, A Golding, V Rus, NB Karabin, S Li, CJ Lescott, S Bobbala, ... ACS Biomaterials Science & Engineering 7 (12), 5666-5677, 2021 | 5 | 2021 |
| Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer M Allen, E Scott, A Golding, G Szeto, NB Karabin US Patent 11,311,485, 2022 | | 2022 |
| Targeted Delivery of Chloroquine to Plasmacytoid Dendritic Cells Enhances Inhibition of the Type I Interferon Response ME Allen, A Golding, V Rus, NB Karabin, S Li, CJ Lescott, S Bobbala, ... bioRxiv, 2021.06. 09.447773, 2021 | | 2021 |
| Nanostructures Encapsulating Antimalarial Drugs for Improved Systemic Lupus Erythematosus Treatment ME Allen University of Maryland, Baltimore County, 2021 | | 2021 |
| Improved antimalarial delivery to inflammatory cells driving lupus pathogenesis using shape-based targeting nanoparticles M Allen, N Karabin, A Golding, E Scott, G Szeto The Journal of Immunology 202 (1_Supplement), 132.15-132.15, 2019 | | 2019 |
